Abbott starts new trial to assess early use benefit of HeartMate 3
The study aims to identify heart failure patients who may benefit from using the company’s HeartMate3 LVAD.
25 October 2024
25 October 2024
The study aims to identify heart failure patients who may benefit from using the company’s HeartMate3 LVAD.
This approval is expected to help in treatment of persistent AFib and for RF ablation of CTI dependent atrial flutter.
Amazon says that sensors on the system may collect and analyse user data and apply external forces to mitigate the effects of OSA.
The UK public body has urged the use of the Manchester developed TriageHF Plus after research found it cut hospitalisations by 58%.
The Sonara Health Phase II trial will examine how its remote monitoring app impacts the overall treatment quality of methadone users.
The development focuses not only on biomechanical fixation but also on the essential blood flow role in tendon-to-bone healing.
The study aims to drive earlier diagnosis of genetic diseases and early intervention to improve the health of the participating babies.
Healthcare systems are under increasing pressure to manage the complex needs of older adults. Medical devices, particularly wearable technologies and remote monitoring tools, are becoming essential in this effort.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.